BE1007586A3 - Produits pharmaceutiques. - Google Patents

Produits pharmaceutiques. Download PDF

Info

Publication number
BE1007586A3
BE1007586A3 BE9400928A BE9400928A BE1007586A3 BE 1007586 A3 BE1007586 A3 BE 1007586A3 BE 9400928 A BE9400928 A BE 9400928A BE 9400928 A BE9400928 A BE 9400928A BE 1007586 A3 BE1007586 A3 BE 1007586A3
Authority
BE
Belgium
Prior art keywords
sep
treatment
aciclovir
patients
use according
Prior art date
Application number
BE9400928A
Other languages
English (en)
French (fr)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of BE1007586A3 publication Critical patent/BE1007586A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Catching Or Destruction (AREA)
BE9400928A 1993-10-16 1994-10-14 Produits pharmaceutiques. BE1007586A3 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939321394A GB9321394D0 (en) 1993-10-16 1993-10-16 Pharmaceuticals

Publications (1)

Publication Number Publication Date
BE1007586A3 true BE1007586A3 (fr) 1995-08-16

Family

ID=10743678

Family Applications (1)

Application Number Title Priority Date Filing Date
BE9400928A BE1007586A3 (fr) 1993-10-16 1994-10-14 Produits pharmaceutiques.

Country Status (9)

Country Link
EP (1) EP0723448A1 (ja)
JP (1) JPH09503779A (ja)
AU (1) AU7860394A (ja)
BE (1) BE1007586A3 (ja)
CA (1) CA2174240A1 (ja)
FR (1) FR2711061B1 (ja)
GB (2) GB9321394D0 (ja)
WO (1) WO1995011027A1 (ja)
ZA (1) ZA948065B (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ508489A (en) * 1998-07-09 2004-06-25 Warner Lambert Co Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
D.R.C. ROBERTSON ET AL.: "Treatment of post herpetic neuralgia in the elderly.", BR. MED. BULL., vol. 46, no. 1, 1990, pages 113 - 123 *
K.E. SCHMADER ET AL: "Are current therapies useful for the prevention of postherpetic neuralgia?", J. GEN. INTERN. MED., vol. 4, no. 2, 1989, pages 83 - 89 *
M.J. WOOD ET AL.: "Herpes zoster and pain.", SCAND. J. INFECT. DIS., vol. 23, no. 80, 1991, pages 53 - 61 *
P. KLENERMAN ET AL.: "Acyclovir and postherpetic neuralgia.", BIOMED. PHARMACOTHER., vol. 44, no. 9, 1990, pages 455 - 459 *

Also Published As

Publication number Publication date
FR2711061B1 (fr) 1995-12-01
WO1995011027A1 (en) 1995-04-27
GB2282759A (en) 1995-04-19
JPH09503779A (ja) 1997-04-15
GB9420754D0 (en) 1994-11-30
ZA948065B (en) 1996-04-10
CA2174240A1 (en) 1995-04-27
FR2711061A1 (fr) 1995-04-21
EP0723448A1 (en) 1996-07-31
AU7860394A (en) 1995-05-08
GB9321394D0 (en) 1993-12-08

Similar Documents

Publication Publication Date Title
EP0336851B1 (fr) Composition pharmaceutique pour administration orale à base d'un dérivé d'acide diphosphonique
FR2578421A1 (fr) Compositions pharmaceutiques utiles pour le traitement des troubles de la memoire
DK175621B1 (da) Præparater med forbedret penetration
WO1988005297A1 (fr) Utilisation d'antagonistes de la morphine dans la preparation de medicaments a effet immunomodulateur et anti-viral, destines notamment a traiter les etats immuno-deficitaires acquis
FR2530468A1 (fr) Composition analgesique et anti-inflammatoire contenant de l'ibuprofen
WO1999001132A1 (fr) Medicament, contenant de la yohimbine et de l'arginine, destine a traiter les dysfonctions erectiles
BE1009181A5 (fr) Compositions destinees au traitement de l'infection et des maladies provoquees par le virus de l'hepatite b (hbv).
FR2608428A1 (fr) Composition therapeutique a base de cysteine, pour les complications diabetiques
BE1007586A3 (fr) Produits pharmaceutiques.
DE3785689T2 (de) Verwendung von prostaglandin-biosynthese-hemmer.
EP2150253B1 (fr) Utilisation du 4-cyclopropylmethoxy-n-(3,5-dichloro-1 -oxydo- pyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide pour le traitement des traumatismes de la moelle epiniere
EP0739629B1 (fr) Nouvelles associations comprenant du (-)hydroxycitrate et présentant notamment de nouvelles activités thérapeutiques
BE1000265A3 (fr) Nouvelle association medicamenteuse.
JP2000507211A (ja) 単純ヘルペス感染症の組合せ治療におけるヌクレオシド類似体
EP0413694B1 (fr) Preparations medicamenteuses cardio-protectrices comprenant l'amiodarone, un derive nitre, notamment le dinitrate d'isosorbide et facultativement un beta-bloqueur
EP0966276B1 (fr) Utilisation d'agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants
WO2005007070A2 (en) Stable pharmaceutical composition
EP1469845B1 (fr) Derives de l'acide haloacetamidobenzoique et leur utilisation pour le traitement de maladies parasitaires
FR2845916A1 (fr) Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2702149A1 (fr) Application de la lamotrigine dans le traitement du neuro-sida.
JP2538422B2 (ja) ５―フルオロウラシル類により起こる炎症の発生を抑制する非注射剤形態の制癌剤
US7323471B1 (en) Topical azathioprine for the treatment of oral autoimmune diseases
WO2019008239A1 (fr) Iméglimine pour la prévention et/ou le traitement du carcinome hépatocellulaire
JPH09506883A (ja) 薬 剤
LU85951A1 (fr) Composition pharmaceutique utilisable dans le traitement des maladies des voies urinaires,son procede de preparation et methode d'utilisation de cette composition

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SMITHKLINE BEECHAM P.L.C.

Effective date: 19981031